Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01947283 · ClinicalTrials.gov registry record · NA

Effectiveness of DECIDE in Patient-Provider Communication, Therapeutic Alliance & Care Continuation

A NA study, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
481
Enrollment target

NCT01947283: Completed NA study, sponsored by Massachusetts General Hospital.

NCT01947283 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 481 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (66% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01947283, a NA study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
481 participants
Enrollment target

Study Summary

The purpose of this study is to learn more about how patients and healthcare providers interact in order to improve shared decision making. The investigators plan to test an intervention with two separate educational components-one for patients and one for providers-designed to encourage patients to ask questions and increase their level of involvement in their own care, while simultaneously training providers to be more receptive to patients' questions and concerns. Patients in the intervention group will receive three short (30-45 minute) trainings focused on developing and asking questions and will be interviewed three times over the course of the intervention to see how it has affected the quality of their care. Providers receiving the intervention will participate in three separate trainings, including a 12-hour group workshop, an additional two hour training, and six hours of individual instruction, including personalized feedback based on three audio-recorded patient visits. Previous studies looking at patient engagement and involvement in decision-making have shown that increased engagement is linked with improved outcomes, but that providers are sometimes not prepared to develop a collaborative relationship with patients. The investigators think that training both patients and providers to work together and communicate more effectively will improve quality of care and increase patient satisfaction more than interventions that focus on only one side of the clinical encounter. One of the major goals in studying patient-provider communication is to improve shared decision-making and see how it contributes to racial and ethnic disparities in mental health care, since minority patients have been shown to be less involved in care and have been shown to be perceived and treated differently by providers.

Primary Outcome

12 items designed to assess SDM quality in medical visit. Rated on 5 point Likert scales ranging from 0 (behavior not observed) -- 4 (clinician exhibited behavior to high standard). Final scores are the sum of the rating and range from 0-44. Final scores were transformed to a scale that ranges from 0 (lowest SDM) - 100 (highest SDM).

Interventions

  • BEHAVIORAL DECIDE-PA
  • BEHAVIORAL DECIDE-PC

Trial Details

FieldValue
Enrollment Target 481 participants
Start Date 2013-09
Est. Completion 2016-10
Phase NA
Massachusetts General Hospital

2,032 total trials

What the finished NCT01947283 record still lists

NCT01947283 is an interventional study that assigns participants to a tested intervention. The registered 481 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (66% lower).

The record links to 0 conditions, and to 2 interventions - of which DECIDE-PA is the first listed.

NCT01947283 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01947283 about?

NCT01947283 is a clinical study titled "Effectiveness of DECIDE in Patient-Provider Communication, Therapeutic Alliance & Care Continuation". The purpose of this study is to learn more about how patients and healthcare providers interact in order to improve shared decision making. The investigators plan to test an intervention with two separate educational components-one for patients and one for providers-designed to encourage patients to...

What is the current status of trial NCT01947283?

This trial is currently completed. It is a NA study. The enrollment target is 481 participants. The study started on 2013-09. Estimated completion is 2016-10.

What interventions are being tested in trial NCT01947283?

The interventions under investigation include: DECIDE-PA (BEHAVIORAL), DECIDE-PC (BEHAVIORAL).

Who is sponsoring clinical trial NCT01947283?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01947283's enrollment target sits among peer trials

481 216th of 2000 higher than 1,785 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04449458 · 482 participants · NA

    The Positively Quit Trial for Smoking Cessation

  • NCT07079631 · 482 participants · Phase 1

    A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment BNT327 and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer

  • NCT01954992 · 480 participants · Phase 3

    Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer

  • NCT03023696 · 480 participants · NA

    Can Prophylactic Foraminotomy Prevent C5 Palsy

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01947283, the US trial registry maintained by the National Library of Medicine. NCT01947283 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.